Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niv Papo

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|July 27, 2004
In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteriaAmir Braunstein, Niv Papo, Yechiel Shai
Nature Communications|January 17, 2020
Generating quantitative binding landscapes through fractional binding selections combined with deep sequencing and data normalizationMichael Heyne, Niv Papo, Julia M Shifman
Protein Engineering, Design & Selection : PEDS|February 17, 2022
Modifying pH-sensitive PCSK9/LDLR interactions as a strategy to enhance hepatic cell uptake of low-density lipoprotein cholesterol (LDL-C)Lital Ben-Naim, Isam Khalaila, Niv Papo
Oncotarget|September 4, 2018
Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cellValeria Arkadash, Evette S Radisky, Niv Papo
The Journal of Biological Chemistry|March 21, 2003
A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in miceNiv Papo, Michal Shahar, Lea Eisenbach, et al.
Proteins|July 22, 2021
Predicting mutant outcome by combining deep mutational scanning and machine learningHagit Sarfati, Si Naftaly, Niv Papo, et al.
Journal of Molecular Biology|June 17, 2008
Concerted release of substrate domains from GroEL by ATP is demonstrated with FRETNiv Papo, Yakov Kipnis, Gilad Haran, et al.
Cancer Research|August 18, 2004
Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid Peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretionNiv Papo, Amir Braunstein, Zelig Eshhar, et al.
The Biochemical Journal|September 15, 2018
An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viabilityOfek Oren, Victor Banerjee, Ran Taube, et al.
New Biotechnology|May 7, 2026
Multi-specific targeting of CD44 and the catalytic and hemopexin domains of MMP9 as a therapeutic strategy for osteoclast inhibitionDan Pasternak, Shani Ohayon, Noam Levaot, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|July 27, 2004
In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteriaAmir Braunstein, Niv Papo, Yechiel Shai
Nature Communications|January 17, 2020
Generating quantitative binding landscapes through fractional binding selections combined with deep sequencing and data normalizationMichael Heyne, Niv Papo, Julia M Shifman
Protein Engineering, Design & Selection : PEDS|February 17, 2022
Modifying pH-sensitive PCSK9/LDLR interactions as a strategy to enhance hepatic cell uptake of low-density lipoprotein cholesterol (LDL-C)Lital Ben-Naim, Isam Khalaila, Niv Papo
Oncotarget|September 4, 2018
Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cellValeria Arkadash, Evette S Radisky, Niv Papo
The Journal of Biological Chemistry|March 21, 2003
A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in miceNiv Papo, Michal Shahar, Lea Eisenbach, et al.
Proteins|July 22, 2021
Predicting mutant outcome by combining deep mutational scanning and machine learningHagit Sarfati, Si Naftaly, Niv Papo, et al.
Journal of Molecular Biology|June 17, 2008
Concerted release of substrate domains from GroEL by ATP is demonstrated with FRETNiv Papo, Yakov Kipnis, Gilad Haran, et al.
Cancer Research|August 18, 2004
Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid Peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretionNiv Papo, Amir Braunstein, Zelig Eshhar, et al.
The Biochemical Journal|September 15, 2018
An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viabilityOfek Oren, Victor Banerjee, Ran Taube, et al.
New Biotechnology|May 7, 2026
Multi-specific targeting of CD44 and the catalytic and hemopexin domains of MMP9 as a therapeutic strategy for osteoclast inhibitionDan Pasternak, Shani Ohayon, Noam Levaot, et al.
Pageof 9